|
Hematology
|
|
Red blood cells
|
379 × 104/μl
|
(386–492)
|
|
Hemoglobin
|
11.3 g/dl
|
(11.6–14.8)
|
|
Hematocrit
|
33.7%
|
(35.1–44.4)
|
|
White blood cells
|
3600/μl
|
(3300–8600)
|
|
Platelets
|
20.9 × 104/μl
|
(15.8–34.8)
|
|
Blood chemistry
|
|
Fasting plasma glucose
|
65 mg/dl
|
(70–109)
|
|
Immunoreactive insulin
|
< 0.2 μU/ml
|
(2.2–12.4)
|
|
Glycated hemoglobin
|
5.2%
|
(4.6–6.2)
|
|
Total cholesterol
|
161 mg/dl
|
(142–248)
|
|
Triglycerides
|
62 mg/dl
|
(30–117)
|
|
Total protein
|
6.2 g/dl
|
(6.6–8.1)
|
|
Albumin
|
3.7 g/dl
|
(4.1–5.1)
|
|
Aspartate aminotransferase
|
31 IU/L
|
(13–30)
|
|
Alanine aminotransferase
|
12 IU/L
|
(7–23)
|
|
Creatine phosphokinase
|
59 IU/L
|
(41–153)
|
|
Urea nitrogen
|
11.4 mg/dl
|
(8.0–18.4)
|
|
Creatinine
|
0.66 mg/dl
|
(0.46–0.79)
|
|
Uric acid
|
2.5 mg/dl
|
(2.6–5.5)
|
|
Sodium
|
124 mEq/L
|
(137–147)
|
|
Potassium
|
4.8 mEq/L
|
(3.5–4.7)
|
|
Chloride
|
90 mEq/L
|
(98–108)
|
|
Calcium
|
8.7 mg/dl
|
(8.8–10.1)
|
|
C-reactive protein
|
0.16 mg/dl
|
(0–0.14)
|
|
Immunoglobulin G4
|
35 mg/dl
|
(5–117)
|
|
Carcinoembryonic antigen
|
208.0 ng/ml
|
(0–4.76)
|
|
Sialyl-Lewis X
|
26.6 U/ml
|
(0–37.9)
|
|
Cytokeratin 19 fragments
|
1.6 ng/ml
|
(0–2.1)
|
|
Squamous cell carcinoma antigen
|
1.1 ng/ml
|
(0–1.5)
|
|
Plasma osmolality
|
254 mOsm/L
|
(275–290)
|
|
Arginine vasopressin
|
1.0 pg/ml
| |
|
Thyroid-stimulating hormone
|
4.84 μIU/ml
|
(0.50–5.00)
|
|
Free thyroxine
|
1.44 ng/dl
|
(0.90–1.70)
|
|
Free triiodothyronine
|
3.22 pg/ml
|
(2.30–4.00)
|
|
Adrenocorticotropic hormone
|
2.6 pg/ml
|
(7.2–63.3)
|
|
Serum cortisol
|
< 0.2 μg/dl
|
(4.5–21.1)
|
|
Dehydroepiandrosterone sulfate
|
< 20 ng/ml
|
(120–1330)
|
|
Plasma renin activity
|
0.2 ng/ml/h
|
(0.2–2.3)
|
|
Aldosterone
|
8.8 ng/dl
|
(3.0–15.9)
|
- The reference range for each parameter is shown in parentheses
- Blood samples were taken in the morning (10 a.m.) with the patient in supine position. The patient was taking thyroid hormone replacement therapy with oral levothyroxine (50 μg/day) for primary hypothyroidism
